Research Papers

Journal Publications

1. Anjali Kumari, Bonthu Varunteja, Satyajit Mohanty, Anjali Mishra, Nayan Gupta, Tuhin Mukherjee, Bhawna Sharma, Nikita Nayak, Anwesha Sahu, Ashok Pattnaik, Pranav Kumar Prabhakar & Uttam Kumar Mishra. Combination therapy, a new tool for the management of Obesity. AAPS PharmSciTech 2026, 27, 196. (IF: 5.1). 

DOI/Link: https://doi.org/10.1208/s12249-025-03284-4.

2. S. Kalia, Pranav Kumar Prabhakar, V. Dhiman, S. Singh, N. Tandon, A. Singh, and Nupur Prasad. Long-term stability and antibacterial efficiency of Cu–Zn co-doped cobalt ferrite-based composites. Dalton Transactions 2026, 55, no. 9, 3917-3933. (IF: 3.3)

DOI/Link: https://doi.org/10.1039/D5DT02692J

3. Priyanka Gupta, Biplab Debnath, Sumel Ashique, Mohhammad Ramzan, Sabina Yasmin, Eman Shorog, Shubhrajit Mantry, Mohd Tariq, Sathvik Belagodu Sridhar, Uttam Prasad Panigrahy, Himanshu Sharma, Asif Iqbal, Pranav Kumar Prabhakar & Md Yousuf Ansari. The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties. Inflammopharmacology, 2026, 34(1), 227–242. (IF: 6.3)

DOI/Link: https://doi.org/10.1007/s10787-025-02005-4 

4. Ashok Kumar Sah, Joy Das, Abdulkhakov Ikhtiyor Umarovich, Shagun Agarwal, Pranav Kumar Prabhakar, Ankur Vashishtha, Rabab H. Elshaikh, Ranjay Kumar Choudhary, Ayman Hussein Alfeel. Targeting Cancer Stem Cells with Phytochemicals: Molecular Mechanisms and Therapeutic Potential. Biomedicines. 2026. 14(1):215. (IF: 4.5)

DOI/Link: https://doi.org/10.3390/biomedicines14010215

5. Ashok Kumar Sah, Rabab H. Elshaikh, Manar G. Shalabi, Anass M. Abbas, Pranav Kumar Prabhakar, Asaad M. A. Babker, Ranjay Kumar Choudhary, Vikash Gaur, Ajab Singh Choudhary, Shagun Agarwal. Role of Artificial Intelligence and Personalized Medicine in Enhancing HIV Management and Treatment Outcomes. Life. 2025; 15(5):745. (IF: 3.9)

DOI/Link: https://doi.org/10.3390/life15050745

6. Satyajit Mohanty, Anwesha Sahu, Tuhin Mukherjee, Sneha Kispotta, Payel Mal, Muskan Gupta, Jeet Kumar Ghosh, Pranav Kumar Prabhakar. Molecular mechanisms and treatment strategies for estrogen deficiency-related and glucocorticoid-induced osteoporosis: a comprehensive review. Inflammopharmacology 2025, 33, 2409–2445. (IF: 6.3).

DOI/Link: https://doi.org/10.1007/s10787-025-01749-3

7. Keshav Anand, Debojyoti Mandal, Pranav Kumar Prabhakar. Phytochemical profiling, in-vitro antioxidant, and antidiabetic evaluation of Morchella esculenta: a comprehensive investigation. Letters in Applied NanoBioSciences. 2025, 14 (1), 1-13. 

DOI/Link: https://doi.org/10.33263/LIANBS141.043

8. Sanjeev Kumar Sahu, Pranav Kumar Prabhakar, Manish Vyas. Therapeutical potential of natural products in treatment of pancreatic cancer: a review. Molecular Biology Reports, 2025, 52, 179. (IF: 3.2)

DOI/Link:  https://doi.org/10.1007/s11033-025-10287-8

9. Sanjeev Kumar Sahu, Manish Vyas, Pranav Kumar Prabhakar. Emerging Role of Natural Topoisomerase Inhibitors as Anticancer agents. Medicinal Chemistry, 2025, 21 (3); 195-210. (IF: 2.5)

DOI/Link:  http://dx.doi.org/10.2174/0115734064311729240911102646

10. Mohd Afzal, Shagun Agarwal, Rabab H. Elshaikh, Asaad M. A. Babker, Einas Awad Ibrahim Osman, Ranjay Kumar Choudhary, S. Jaiswal, Farhana Zahir, Pranav Kumar Prabhakar, Anass M. Abbas, Manar G. Shalabi, Ashok Kumar Sah. Innovative Diagnostic Approaches and Challenges in the Management of HIV: Bridging Basic Science and Clinical Practice. Life 2025. 15 (2), 209. (IF: 3.9)

DOI/Link:  https://doi.org/10.3390/life15020209 

11. Mohd Afzal, Shagun Agarwal, Rabab H. Elshaikh, Asaad M. A. Babker, Ranjay Kumar Choudhary, , Pranav Kumar Prabhakar, Farhana Zahir, Ashok Kumar Sah. Carbon Monoxide Poisoning: Diagnosis, Prognostic Factors, Treatment Strategies, and Future Perspectives. Diagnostics. 2025. 15 5: 581. 

DOI/Link: https://doi.org/10.3390/diagnostics15050581

12. Ashok Kumar Sah, Darla Srinivasa Rao, Anass M Abbas, M Chandrasekar, Mohamed Ahmed Mohamed Adam, Ajab Singh Choudhary, Ranjay Kumar Choudhary, Rabab H. Elshaikh, Pranav Kumar Prabhakar, Syrsulu Myrzagulova, Rohit Rathore, Asaad M. Babker, Devendra Prasad,  Shagun Agarwal. The future of diagnostics: cutting-edge advances in healthcare technology. (2025). Italian Journal of Medicine, 2025, 19(2)., 1932. (IF: 0.4)

DOI/Link: https://doi.org/10.4081/itjm.2025.1932

13. Rupendra Shakya, P.M. Sivakumar, Pranav Kumar Prabhakar. Gut Microbiota and Diabetes: Pioneering New Treatment Frontiers. Endocrine Metabolic Immune Disorders- Drug Targets. 2025. 25(10),767-776 (IF: 2.0)

DOI/Link: http://dx.doi.org/10.2174/0118715303342579241119155225 

14. Allan Amooti Ahikiriza, Sarad Pawar Naik Bukke, Tadele Mekuriya Yadesa, Buyinza Nicholas, Kasolo Daniel, Kabali Moses, Sewalu Mathias Bonny Ddumba, Pranav Kumar Prabhakar. The Potential of Natural Products in Metabolic Disease Management: A Thorough Exploration of the Case of Uganda. Endocrine Metabolic Immune Disorders-Drug Targets, 2025 (IF: 2.0)

DOI/Link: https://doi.org/10.2174/1871530323666230825140808 

15. Satyajit Mohanty, Nikita Nayak, Tuhin Mukherjee, Shivangi Kumari, Pranav Kumar Prabhakar, Ashok Pattnaik. Mobilizing Stockpile of Nature: Phytochemicals, Herbal Extracts, and Dietary Supplements for Managing Metabolic Diseases with Concentric Focus on Obesity. Endocrine Metabolic Immune Disorders-Drug Targets, 2025. 25(12), 960 - 992. (IF: 1.9)

DOI/Link: http://dx.doi.org/10.2174/0118715303316634240822073810 

16. Satyajit Mohanty, Manmeet Kaur Khanna, Krishnendu Adhikary, Tuhin Mukherjee, Anwesha Sahu, Ivan Kahwa, Pranav Kumar Prabhakar, Mahendra Pratap Swain, Anasuya Sahoo, Manoj Kumar Parida. Combating TB Pathology: Advanced Diagnostics, Innovative Therapies, and Public Health Strategies: A Review. Curr Pharm Biotechnol. 2025. 

DOI/Link: http://dx.doi.org/10.2174/0113892010355430250330074301.

17. Rupal Dubey, Sourbh Suren Garg, Navneet Khurana, Pranav Kumar Prabhakar, Jeena Gupta. Sinapic acid accelerates diabetic wound healing by promoting angiogenesis and reducing oxidative stress. Scientific Reports. 2025. 15, 33796 (IF: 3.9).

DOI/Link: https://doi.org/10.1038/s41598-025-03890-z 

18. Joy Das, Ashok Kumar Sah, Ranjay Kumar Choudhary, Rabab H. Elshaikh, Utpal Bhui, Shreya Chowdhury, Anass M. Abbas, Manar G. Shalabi, Nadeem Ahmad Siddique, Raji Rubayyi Alshammari, Navjyot Trivedi, Khoula Salim Ali Buwaiqi, Said Al Ghenaimi, Pranav Kumar Prabhakar. Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies. Biomedicines, 2025, 13(7), 1532. 

DOI/Link: https://doi.org/10.3390/biomedicines13071532 

19. Satyajit Mohanty, Anjali Mishra, Nayan Gupta, Bonthu Varunteja, Tuhin Mukherjee, Pujarani Pradhan, Anjali Kumari, Nikita Nayak, Anwesha Sahu, Pranav Kumar Prabhakar, Ashok Pattnaik,  Mohammad Azam Ansari. Sericin as a next-generation biomaterial: Properties, applications, and future prospects. International Journal of Biological Macromolecules 2025. 145393. (IF: 8.7)

DOI/Link: https://doi.org/10.1016/j.ijbiomac.2025.145393 

20. Adwitiya Mitra, Ayesha Shahid, Shivangi Kumari, Tuhin Mukherjee, Shiladitya Pramanick, Satyajit Mohanty, Mohammad Azam Ansari, Krishnendu Adhikary, Pranav Kumar Prabhakar, Kavindra Kumar Kesari. Optimizing wound healing: insights from phytochemicals and advanced therapies. Inflammopharmacology. 2025. 33, 4009–4035 (IF: 6.3). 

DOI/Link: https://doi.org/10.1007/s10787-025-01806-x 

21. Sah AK, Afzal M, Elshaikh RH, Abbas AM, Shalabi MG, P. K. Prabhakar, Babker AMA, Khalimova FT, Sabrievna VA, Choudhary RK. Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes. Life. 2025; 15(5):779. (IF: 3.9)

DOI/Link: https://doi.org/10.3390/life15050779

22. Bineesh CP, Vipin Viswanath, Vimal MV, Pranav Kumar Prabhakar*. Association of Adipokine Levels and Insulin Resistance in Prediabetes: Hospital-Based Descriptive Study in a Tertiary Care Hospital in North Kerala. International Journal of Diabetes in Developing Countries. 2024, 44, 373-378. (IF: 0.8) 

DOI/Link: https://doi.org/10.1007/s13410-023-01248-7

23. Ayaz Shahid, Ajit Prakash, Saad Mustafa, Pranav Kumar Prabhakar (Editorial) New mechanisms for anti-cancer drugs. Frontiers in Pharmacology, 2024, 15, 1387942 (IF: 0.9)

DOI/Link: https://doi.org/10.3389/fphar.2024.1387942 

24. Pranav Kumar Prabhakar (Editorial): COVID-19 and diabetes: Current findings and future perspectives. Front. Endocrinol. 2024, 15: 1421721. 

DOI/Link: https://doi.org/10.3389/fendo.2024.1421721

25. Pranav Kumar Prabhakar, Bineesh CP, Vipin Viswanath, Vimal MV. Association of Adipokine Gene Polymorphism and Serum Adipokine Levels in Prediabetic Population. Letters in Applied NanoBioSciences. 2024, 13(2), 76. 

DOI/Link: https://doi.org/10.33263/ LIANBS132.076

26. Pranav Kumar Prabhakar, Gaber El-Saber Batiha. Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2. Current Medicinal Chemistry, 2024. 31(21), 3167-3181 (IF:  3.2).

DOI/Link: https://doi.org/10.2174/0929867330666230501172557

27. Aishwarya Laxmi, Sourbh Suren Garg, Arnika Singh, Pranav Kumar Prabhakar, Jeena Gupta. Histone Modifying Potential of Dietary Phytochemicals: Implications in Treating Breast Cancer. Current Pharmacology Reports. 2023, 9, 489–510. (IF: 1.8). 

DOI/Link: https://doi.org/10.1007/s40495-023-00338-8

28. Aayushi Velingkar, Sugunakar Vuree, Pranav Kumar Prabhakar, Rajender Rao Kalshikam, Suresh Kondeti. Fibroblast Growth Factor 21 as a Potential Master Regulator in Metabolic Disorders. American Journal of Physiology-Endocrinology and Metabolism, 2023, 324 (5), E409 - E424 (IF: 5.9)

DOI/Link: https://doi.org/10.1152/ajpendo.00244.2022 

29. Pranav Kumar Prabhakar, Navneet Khurana, Manish Vyas, Vikas Sharma, Gaber El-Saber Batiha, Harpreet Kaur, Jashanpreet Singh, Deepak Kumar, Neha Sharma, Ajeet Kaushik, Raj Kumar. Aspects of Nanotechnology for COVID-19 vaccines development and its delivery application. Pharmaceutics (MDPI), 2023, 15(2), 451 (IF: 6.9)

DOI/Link: https://doi.org/10.3390/pharmaceutics15020451 

30. Sweta Kumari, Biplab Pal, Sanjeev Kumar Sahu, Pranav Kumar Prabhakar, Devesh Tewari. Adverse events of clenbuterol among athletes: a systematic review of case reports and case series. International Journal of Legal Medicine, 2023, 137(4), 1023-1037. (IF:  2.6).

DOI/Link: https://doi.org/10.1007/s00414-023-02996-1 

31. Mutiu A. Alabi, Marvis A. Arowolo, Asiat Na'Allah, Pranav Kumar Prabhakar, Eberechukwuka G. Linus , Sesan A. Aransiola, Hassan T. Abdulameed, Beloved K. Ajani, Naga Raju Maddela, Ram Prasad. Phytochemicals and anticancer activity of methanol extract of Trigonella foenum-greacum seed on breast cancer cell lines. South African Journal of Botany. 2023, 160, 273-281. (IF: 3.1). 

DOI/Link: https://doi.org/10.1016/j.sajb.2023.07.021 

32. Anush Nazar, Jasmin Anush, Riju Mathew, Pranav Kumar Prabhakar. Clinical Utility of Small, Dense LDL as an Atherogenic Risk Marker. Biointerface Res. Appl. Chem. 2023. 13(2). 1-15.

DOI/Link: https://doi.org/10.33263/BRIAC132.199

33. Rupal Dubey, Pranav Kumar Prabhakar, Jeena Gupta. Epigenetics: key to improve delayed wound healing in type 2 diabetes. Molecular and Cellular Biochemistry. 2022. 477, 371–383. (IF: 4.7).

DOI/Link: https://doi.org/10.1007/s11010-021-04285-0

34. R. Dubey, Pranav Kumar Prabhakar, J. Gupta. Identification of Structurally Similar Phytochemicals to Quercetin with High SIRT1 Binding Affinity and Improving Diabetic Wound Healing by Using In silico Approaches. Biointerface Res. Appl. Chem. 2022. 12(6). 7621-7632. 

DOI/Link: https://doi.org/10.33263/BRIAC126.76217632

35. P. M. Sivakumar, Sibel Cetinel, Pranav Kumar Prabhakar, Neelakandan, R. V. Prabhawathi. Molecular insights on the Therapeutic effect of Selected Flavonoids on Diabetic Neuropathy. Mini-Review in Medicinal Chemistry. 2022. 22(14), 1828-1846. (IF: 4.0).

DOI/Link: https://doi.org/10.2174/1389557522666220309140855

36. Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Gomaa Mostafa-Hedeab, Rupal Dubey, Pranav Kumar Prabhakar, Gaber El-Saber Batiha. Covid 19 and diabetes: do novel drugs for diabetes will help in covid 19? Current Molecular Pharmacology, 2022, 16(4), 494 - 506.  (IF:3.339).

DOI/Link: http://dx.doi.org/10.2174/1874467215666220908091604 

37. Yachna Mishra, Hawraz Ibrahim M. Amin, Vijay Mishra, Manish Vyas, Pranav Kumar Prabhakar, Mukta Gupta, Rajeev Kanday et al. Application of nanotechnology to herbal antioxidants as improved phytomedicine: An expanding horizon. Biomedicine & Pharmacotherapy 2022, 153: 113413. (IF: 7.5).

DOI/Link: https://doi.org/10.1016/j.biopha.2022.113413

38. Abhilasha Suwalka, Balram Sharma, Pranav Kumar Prabhakar. A Study on Diabetic Patients Related To Functions of Fibroblast Growth Factor-23 on Bone Metabolism. Journal of Pharmaceutical Negative Results, 2022 (13, sp issue 5), 1008-1022.

DOI/Link: https://www.pnrjournal.com/index.php/home/article/view/2619

39. Pranav Kumar Prabhakar (Editorial). Pathophysiology of diabetic secondary complication and their management. Current Diabetes Reviews, 2021; 17(4); 395 – 396.

DOI/Link: https://doi.org/10.2174/157339981704210326092455

40. V. Manimaran, P. M. Sivakumar, J. Narayanan, S. Parthasarathi, Pranav Kumar Prabhakar. Nanoemulsions- A better Approach for Anti Diabetic Drugs Delivering. Current Diabetes Review. 2021; 17(4); 486–495. (IF: 2.6)

DOI/Link: https://doi.org/10.2174/1573399817666201209095205

41. C.P. Bineesh, S. Maity, D. S. Gaikwad, N. Anush, N. Kaur, Pranav Kumar Prabhakar. Interaction of red onion and amla with vancomycin against Escherichia coli and Klebsiella pneumoniae. Plant Cell Biotechnology and Molecular Biology. 2021; 22(5-6); 100 – 107.

DOI/Link: https://ikprress.org/index.php/PCBMB/article/view/5898

42. Aishwarya, V. Chopra, A. Singh, M. Vyas, N. Khurana, Pranav Kumar Prabhakar, M. Gupta, P. Yadav, P. K. Prajapati. Comprehensive review on anticarcinogenic effect of abrin. Plant Cell Biotechnology and Molecular Biology. 2021; 22(19-20); 79-88.

DOI/Link: https://ikprress.org/index.php/PCBMB/article/view/6093

43. S. Sharma, D. S. Baghel, A. Mittal, S. Singh, B. Kumar, Pranav Kumar Prabhakar, A. K. Chaudhary. Polyherbal formulation development and assessment of its potential against urolithiasis (Mutrakricchra) by in-vitro technique. Research Journal of Pharmacy and Technology. 2021; 14(4); 1982 – 1988.

DOI/Link: http://dx.doi.org/10.52711/0974-360X.2021.00351

44. N. Choudhary, Pranav Kumar Prabhakar, G. L. Khatik, S. R. Chamakuri, D. Tewari, A. Suttee. Evaluation of acute toxicity, in-vitro, in-vivo antidiabetic potential of the flavonoid fraction of the plant chenopodium album l. Pharmacognosy Journal. 2021; 13(3); 765 – 779.

DOI/Link: http://dx.doi.org/10.5530/pj.2021.13.98

45. P. M. Sivakumar, V. Prabhawathi, A, Zarrabi, S. Akthar, Pranav Kumar Prabhakar. Current Trends in the Therapeutic Strategies for Diabetes Management. Current Medicinal Chemistry, 2021, 28(23), 4616–4637 (IF: 3.2).

DOI/Link: https://doi.org/10.2174/0929867328666210218183914

46. P. M. Sivakumar, V. Prabhawathi, Prem Kumar, Pranav Kumar Prabhakar. Role of GLP-1 analogues in the management of Diabetes and its secondary complications. Mini-Review in Medicinal Chemistry. 2021, 21 (20), 3166-3182 (IF: 4.0).

DOI/Link: https://doi.org/10.2174/1389557521666210422114909

47. Dinobandhu Nandi, Anshula Sharma, Pranav Kumar Prabhakar. Nanoparticle-assisted therapeutic strategies for effective cancer management. Current Nanoscience, 2020, 16(1), 42-50. (IF:1.9)

DOI/Link: https://doi.org/10.2174/1573413715666190206151757

48. M.Banerjee, R.Khursheed, A.K.Yadav, S.K.Singh, M.Gulati, D.K.Pandey, Pranav Kumar Prabhakar, R.Kumar, O.Porwal, A.Awasthi, Y.Kumari, G.Kaur, C.Ayinkamiye, R.Prashar, D.Mankotia. A Systematic Review on Synthetic Drugs and Phytopharmaceuticals Used to Manage Diabetes. Current Diabetes Reviews, 2020, 16, 340-356. (IF:2.6).

DOI/Link: https://doi.org/10.2174/1573399815666190822165141

49. Pranav Kumar Prabhakar, Deepak Nath, Saurabh Singh, A. Mittal, D. S. Bhaghel. Formulation and evaluation of polyherbal anti-acne combination by using in-vitro model. Biointerface Res. Appl. Chem., 2020, 10(1), 4747 – 4751.

DOI/Link: https://doi.org/10.33263/BRIAC101.747751

50. S.Singh, S.K.Singh, B.Kumar, B.Kaur, A.Attri, R.Khursheed, P.Bawa, A.H.Malik, M.Gulati, N.K.Pandey, Pranav Kumar Prabhakar, D.S.Baghel, O.Porwal, A.K.Yadav. Effect of co-administration of herbal extracts with copper nanoparticles: A novel two-pronged approach in treating type 2 diabetes. Recent Innovation in Chemical Engineering, 2020, 13 (5), 366-378. 

DOI/Link: http://dx.doi.org/10.2174/2405520413999200719140819

51. Pranav Kumar Prabhakar. Siderophore and its application as antimicrobial agents. Current Molecular Pharmacology, 2020, 13(4), 295-305. (IF:3.339).

DOI/Link: https://doi.org/10.2174/1874467213666200518094445

52. Pranav Kumar Prabhakar, Karmveer Singh, Deeraj Kabra, Jeena Gupta. Natural SIRT1 modifiers as promising therapeutic agents for improving diabetic wound healing. Phytomedicine, 76, Article No. 153252 (IF: 11.3).

DOI/Link: https://doi.org/10.1016/j.phymed.2020.153252

53. Pranav Kumar Prabhakar, Jyoti Lakhanpal . Recent advances in the nucleic acid-based diagnostic tool for coronavirus. Molecular Biology Reports, 2020, 47, 9033–9041. (IF:3.2).

DOI/Link: https://doi.org/10.1007/s11033-020-05889-3

54. Abdur Rahim Abidi, Pranav Kumar Prabhakar. Association between diabetes and thyroid disorders. Plant Archive. 2020; 20(2); 3175-3182.

DOI/Link: https://www.plantarchives.org/SPL%20ISSUE%2020-2/523__3175-3182_.pdf

55. Pranav Kumar Prabhakar. Bioreactor strategies to increase the engineered protein production in Lactococcus lactis. Plant Archive. 2020; 20(2); 3183-3191.

DOI/Link: https://www.plantarchives.org/SPL%20ISSUE%2020-2/524__3183-3191_.pdf

56. J. Lakhanpal, N. Banu, Pranav Kumar Prabhakar. Pathophysiology and diagnostic approach of covid-19 - an overview. Plant Archive. 2020; 20(2); 3844-3849.

DOI/Link: 

57. D. S. Gaikwad, N. R. Sharma, Pranav Kumar Prabhakar, J. Singh J. Application of ginger and cinnamon in poultry nutrition on growth performance: A review. Plant Cell Biotechnology and Molecular Biology. 2020; 21(71-72); 172 – 180.

DOI/Link: https://ikprress.org/index.php/PCBMB/article/view/5775

58. J. Singh, Pranav Kumar Prabhakar, N. Neupane. Hospital-Based Clinical Study on Prevalence of TPO Antibodies in Association to Autoimmune Thyroid Diseases in Tertiary Care Hospital. Asian Journal of Pharmaceutical and Clinical Research, 2020, 13 (12), 186-189. 

DOI/Link: https://doi.org/10.22159/ajpcr.2020.v13i12.39513

59. Thomson Soni, Pranav Kumar Prabhakar (Shared first authorship), Sajid Hussain. Increasing Antibiotic Resistance in the Uropathogens. Asian Journal of Pharmaceutics. 2019, 13(1), 1-4.

DOI/Link: https://doi.org/10.22377/ajp.v13i01.3001

60. Anmol Sharma, Pawan Gupta, Pranav Kumar Prabhakar. Endogenous Repair System of Oxidative Damage of DNA. Current Chemical Biology, 2019, 13(2), 1-5. (Citation: 10)

DOI/Link: https://doi.org/10.2174/2212796813666190221152908

61. Pranav Kumar Prabhakar, Sivakumar, P.M. Protein Tyrosine Phosphatase 1B inhibitors: a novel therapeutic strategy for the management of type 2 diabetes mellitus. Current Pharmaceutical Design, 2019, 25(23), 2526-2539. (IF:3.2)

DOI/Link: https://doi.org/10.2174/1381612825666190716102901

62. S. Sharma, J. Gupta, Pranav Kumar Prabhakar, P.Solanki, A.Rajput, P.Gupta. Phytochemical repurposing for identification of novel therapeutic benefits of Sabinene using in-silico and in-vitro approaches. Assay in Drug Development Technologies, 2019, 17(8), 339-351. (IF:1.8)

DOI/Link: https://doi.org/10.1089/adt.2019.939

63. Kamaldeep Singh, Savita Devi, Pranav Kumar Prabhakar. Relationship of TSH with BMI in subclinical hypothyroid patients. Biointerface Res. Appl. Chem., 2019, 9(4), 4193-4198.

DOI/Link: https://doi.org/10.33263/BRIAC94.193198

64. R. P. Jayaswal, M. Vijaysimha, Pranav Kumar Prabhakar. Gut microbiota and diabetes mellitus- An interlinkage. Asian Journal of Pharmaceutical and Clinical Research, 2018, 11 (1), 13-16.

DOI/Link: https://doi.org/10.22159/ajpcr.2018.v11i1.22305

65. A. Sharma, S. Devi, K. Singh, Pranav Kumar Prabhakar. Correlation of body mass index with thyroid-stimulating hormones in thyroid patient. Asian Journal of Pharmaceutical and Clinical Research, 2018, 11 (sp2), 65-68. 

DOI/Link: https://doi.org/10.22159/ajpcr.2018.v11s2.28580

66. N. Neupane, B. Kumari, J. Lakhanpal, A. Bhutani, Pranav Kumar Prabhakar. A Study of Procalcitonin as Biomarker in Sepsis Patients Admitted in Super Speciality Hospital. Asian Journal of Pharmaceutics, 2018, 12(4)(Suppl), S1408-S1412.

DOI/Link: https://doi.org/10.22377/ajp.v12i04.2942

67. A. Jmatia, D. Roy, R. Shil, Pranav Kumar Prabhakar. Bacteriological profile and antimicrobial resistance patterns isolates in pus samples at Agartala Government Medical College. Asian Journal of Pharmaceutical and Clinical Research, 2017, 10 (1), 1-3. 

DOI/Link: https://journals.innovareacademics.in/index.php/ajpcr/article/view/15411

68. N. Neupane, M. Kaur, Pranav Kumar Prabhakar. Treatment of Hashimoto’s thyroiditis with herbal medication. International Journal of Green Pharmacy. 2017, 11(3), S343-S347. 

DOI/Link: https://doi.org/10.22377/ijgp.v11i03.1140

69. R. P. Jayaswal, Pranav Kumar Prabhakar. Probiotics- A new diabetes management tool. International Journal of Green Pharmacy. 2017, 11(3), S395-S400.

DOI/Link: https://doi.org/10.22377/ijgp.v11i03.1147

70. R. Nankar, Pranav Kumar Prabhakar, M. Doble. Hybrid drug combination: Combination of ferulic acid and metformin as anti-diabetic therapy. Phytomedicine. 2017, 37, 10-13. (IF: 11.3)

DOI/Link: https://doi.org/10.1016/j.phymed.2017.10.015

71. Pranav Kumar Prabhakar. Pathophysiology of secondary complications of diabetes mellitus. Asian Journal of Pharmaceutical and Clinical Research, 2016, 9 (1), 32-36. 

DOI/Link: https://journals.innovareacademics.in/index.php/ajpcr/article/view/9898

72. Kirti, Pranav Kumar Prabhakar. Human papilloma virus-associated cervical cancer: A review. Asian Journal of Pharmaceutical and Clinical Research, 2016, 9 (3), 14-17. 

DOI/Link: https://journals.innovareacademics.in/index.php/ajpcr/article/view/10865

73. H. Kaur, M. H. Amini, Pranav Kumar Prabhakar, A. Singh, A. Suttee. Phytochemical Screening and Antimicrobial Activity of Caesalpinia sappan L. Leaves. International Journal of Pharmacognosy and Phytochemical Research, 2016, 8(6), 1064-1069. (Citation: 15)

DOI/Link: https://impactfactor.org/PDF/IJPPR/8/IJPPR,Vol8,Issue6,Article23.pdf

74. G. Kaur, Pranav Kumar Prabhakar, U.R. Lal, A. Suttee. Phytochemical and Biological Analysis of Tinospora cordifolia. International Journal of Toxicological and Pharmacological Research.2016, 8(4), 297-305. 

DOI/Link: https://impactfactor.org/PDF/IJTPR/8/IJTPR,Vol8,Issue4,Article17.pdf

75. P. S. Chakarborty, H. Sapkota, Pranav Kumar Prabhakar. Synergistic Interaction of Cannabis and Garlic with Commercial Antibiotics. International Journal of Pharmacognosy and Phytochemical Research, 2015, 7(1), 193-196. 

DOI/Link: https://impactfactor.org/PDF/IJPPR/7/IJPPR,Vol7,Issue1,Article29.pdf

76. P. Popli, Pranav Kumar Prabhakar. Significance of Tacrolimus Monitoring to Optimize Immunosuppressive Therapy. International Journal of Pharma and Bio Sciences. 2015, 6(2), 191-198.

DOI/Link: 

77. R. D. Akhatala, J. A. Chelvane, Pranav Kumar Prabhakar, P. P. P. Vedanthi, M. Doble, B. Murthy. S., Generation of drugs coated iron nanoparticles through high energy ball milling. Journal of Applied Physics. 2014, 115 (12), 124906-1-4. (IF: 2.7)

DOI/Link: https://doi.org/10.1063/1.4868681

78. S. U. Maaji, Pranav Kumar Prabhakar. Hypovitaminosis D in Type-2 Diabetes mellitus patients; variation with age, sex and season. Indian Journal of Applied Research. 2014, 4 (6), 422-425.

DOI/Link: 

79. R.D. Akhatala, J.A.  Chelvane, Pranav Kumar Prabhakar, B. Venkateswarlu, M. Doble, B. S. Murthy. Influence of Surfactant Variation on Effective Anisotropy and Magnetic Properties of Mechanically Milled Magnetite Nanoparticles and Their Biocompatibility. IEEE Transactions on Magnetics. 2014, 50(11), 1-4 (IF: 1.9)

DOI/Link: https://doi.org/10.1109/TMAG.2014.2324412

80. Pranav Kumar Prabhakar, A. Kumar, M. Doble. Combination therapy: A new strategy to manage diabetes and its complications. Phytomedicine. 2014, 21(2), 123-130. (IF: 11.3)

DOI/Link: https://doi.org/10.1016/j.phymed.2013.08.020

81. Pranav Kumar Prabhakar, R. Prasad, S. Ali, M. Doble. Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Phytomedicine. 2013, 20(6), 488-494. (IF: 11.3)

DOI/Link: https://doi.org/10.1016/j.phymed.2012.12.004

82. Pranav Kumar Prabhakar, M. Doble. Mechanism of action of natural products used in the treatment of diabetes (Invited Review). Chinese Journal of Integrative Medicine. 2011, 17(8), 563-574. (IF: 3.1)

DOI/Link: https://doi.org/10.1007/s11655-011-0810-3

83. Pranav Kumar Prabhakar, M. Doble. Synergistic interaction of berberine and arecoline with commercial oral antidiabetic drugs in 3T3-L1 adipocytes. Therapeutic Advances in Endocrinology and Metabolism. 2011, 2(3), 103-114. (IF: 7.8)

DOI/Link: https://doi.org/10.1177/2042018811411356

84. Pranav Kumar Prabhakar, M. Doble. Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes. Journal of Agricultural and Food Chemistry. 2011, 59 (18), 9835-9844. (IF: 6.7)

DOI/Link: https://doi.org/10.1021/jf2015717

85. Pranav Kumar Prabhakar, S. Raj, S. N. Sawant, M. Doble. Biocompatibilities Studies on polyaniline and polyaniline-silver nanoparticles coated polyurethane composites. Colloids and Surfaces B: Biointerfaces. 2011, 86 (1), 146-153. (IF: 5.9)

DOI/Link: https://doi.org/10.1016/j.colsurfb.2011.03.033

86. Pranav Kumar Prabhakar, S. Vijayaraghavan, J. Philip, M. Doble, M., Biocompatibility studies of functionalized CoFe2O4 magnetic Nanoparticles. Current Nanoscience. 2011, 7(3), 371-376. (IF: 1.9)

DOI/Link: https://doi.org/10.2174/157341311795542435

87. P. M. Sivakumar, Pranav Kumar Prabhakar, M. Doble. Synthesis, antioxidant evaluation and quantitative structure-activity relationship studies of chalcones. Medicinal Chemistry Research. 2011, 20(4), 482-492. (IF: 3.5)

DOI/Link: https://doi.org/10.1007/s00044-010-9342-1

88. Pranav Kumar Prabhakar, M. Doble. Interaction of phytochemicals with hypoglycemic drugs on glucose uptake in L6 myotubes. Phytomedicine. 2011, 18(4), 285-291. (IF: 11.3)

DOI/Link: https://doi.org/10.1016/j.phymed.2010.06.016

89. Pranav Kumar Prabhakar, M. Doble. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine. 2009, 16(12), 1119-1126. (IF: 11.3)

DOI/Link: https://doi.org/10.1016/j.phymed.2009.05.021

90. Pranav Kumar Prabhakar, M. Doble. A target based therapeutic approach towards diabetes mellitus using medicinal plants (Invited Review). Current Diabetes Review. 2008, 4 (4), 291-308. (IF: 2.6)

DOI/Link: http://dx.doi.org/10.2174/157339908786241124

Guest Editor

1. Pranav Kumar Prabhakar. “Advanced Approaches in the Diagnosis and Treatment of Diabetes Mellitus their secondary Complications”. Current Diabetes Review, 2021, 17(4).

2. Pranav Kumar Prabhakar, Ram Prasad, Ponnurengam Malliappan Sivakumar. “Advanced Approaches in the Diagnosis and Treatment of Diabetes Mellitus and Secondary Complications”. Frontiers in Endocrinology, 2022-2023.

3. Pranav Kumar Prabhakar, Ram Prasad. “COVID-19 and Diabetes: Current Findings and Future Perspectives”. Frontiers in Endocrinology, 2023.